# üé® USE CASE VISUAL SPECIFICATIONS
## Visuals, Data & Links for 5 Use Cases

**Created By:** LEAD  
**Date:** 2026-02-12 03:52 PST  
**Purpose:** Visual design specs and supporting data for each use case

---

## USE CASE 1: "PROVE YOU'RE NOT RECKLESS"

### **Visual: Subpoena Comparison (Before/After)**

**Layout:** Split-screen comparison

**Left Side (With PHI - Osmind):**
- üî¥ Red warning banner
- Document icon showing:
  - "Patient: John Smith, DOB: 03/15/1985"
  - "Address: 123 Main St, Portland, OR"
  - "Session notes: Patient reported anxiety..."
- Caption: "Subpoena exposes participant identities"

**Right Side (No PHI - PPN Portal):**
- üü¢ Green checkmark
- Document icon showing:
  - "Site A: 50 psilocybin protocols logged"
  - "Adverse events: 2 (4.0%)"
  - "Safety score: 96/100"
- Caption: "Subpoena returns aggregated data only"

**Supporting Data:**
- DEA Schedule I enforcement statistics
- Oregon Psilocybin Services Act (ORS 475A)
- Religious Freedom Restoration Act citations

**Links:**
- DEA.gov: Controlled Substances Act
- Oregon.gov: Psilocybin Services licensing
- MAPS.org: Legal defense resources

---

## USE CASE 2: "REDUCE MALPRACTICE EXPOSURE"

### **Visual: Safety Score Gauge + Network Benchmark**

**Layout:** Dashboard card with gauge chart

**Gauge Chart:**
- Semicircle speedometer
- Zones: Red (0-25), Yellow (25-50), Blue (50-75), Green (75-100)
- Needle pointing to 92/100
- Label: "Your Safety Score"

**Network Comparison:**
- Bar chart showing:
  - Your site: 2.3% adverse event rate (indigo bar)
  - Network average: 3.1% (gray dotted line)
- Percentile badge: "62nd percentile" (better than 62% of network)

**Supporting Data:**
- Malpractice insurance premium calculator
- Standard-of-care benchmarks for ketamine therapy
- Insurance company risk assessment criteria

**Links:**
- AAPM (American Academy of Pain Medicine) ketamine guidelines
- Malpractice insurance providers (Medical Protective, The Doctors Company)
- State medical board standards

---

## USE CASE 3: "GET REIMBURSEMENT APPROVED"

### **Visual: Revenue Impact Chart (Before/After)**

**Layout:** Horizontal bar chart

**Before PPN:**
- Gray bar: $0 insurance reimbursement
- Label: "0 patients covered"

**After PPN:**
- Indigo bar: $120,000/year
- Label: "20 patients √ó $500/session √ó 12 sessions"
- Breakdown tooltip:
  - "Network safety data: 3.1% adverse events"
  - "Lower than SSRIs: 15% adverse events"
  - "Payer approved coverage based on network benchmarks"

**Supporting Data:**
- Insurance reimbursement codes (CPT codes for ketamine)
- Payer evidence requirements (Aetna, Cigna, BCBS)
- Comparative safety data (ketamine vs. SSRIs, benzodiazepines)

**Links:**
- CMS.gov: Medicare coverage policies
- FAIR Health: Reimbursement rate database
- JAMA Psychiatry: Ketamine efficacy studies

---

## USE CASE 4: "SCALE WITHOUT QUALITY COLLAPSE"

### **Visual: Multi-Site Comparison Dashboard**

**Layout:** Card grid (3 sites)

**Portland Site:**
- Safety score: 95/100 (green)
- Adverse events: 2.1%
- Status: "Performing well"

**Seattle Site:**
- Safety score: 88/100 (blue)
- Adverse events: 3.5%
- Status: "Within normal range"

**Denver Site:**
- Safety score: 72/100 (yellow)
- Adverse events: 4.2%
- Status: "‚ö†Ô∏è Attention needed"
- Alert: "Review protocols with Denver team"

**Supporting Data:**
- Multi-site quality control frameworks
- Franchise/chain operations best practices
- Early warning system thresholds

**Links:**
- Joint Commission: Multi-site accreditation standards
- NCQA: Quality measurement frameworks
- Harvard Business Review: Scaling quality

---

## USE CASE 5: "COMPLY WITH STATE REGULATIONS"

### **Visual: Compliance Report Export**

**Layout:** Document preview with one-click export button

**Report Preview:**
```
Oregon Psilocybin Services
Quarterly Compliance Report - Q1 2026

Facility: Site A (License #PS-2024-001)
Reporting Period: Jan 1 - Mar 31, 2026

Sessions Conducted: 127
Adverse Events: 3 (2.4%)
Safety Score: 97.6/100

Compliance Status: ‚úÖ COMPLIANT
```

**Export Options:**
- üìÑ PDF (for state submission)
- üìä Excel (for internal review)
- üìß Email (to compliance officer)

**Supporting Data:**
- Oregon Psilocybin Services rules (OAR 333-333)
- Colorado Natural Medicine regulations
- Quarterly reporting requirements by state

**Links:**
- Oregon.gov: OHA Psilocybin Services
- Colorado.gov: Natural Medicine Division
- Compliance calendar (quarterly deadlines)

---

## INFOGRAPHIC DESIGN SPEC

### **Title:** "How 'No PHI' Enables All 5 Use Cases"

**Layout:** Vertical infographic (3 sections)

**Section 1: The Problem (Top)**
- Icon: ‚ö†Ô∏è Warning triangle
- Text: "PHI blocks cross-site data sharing"
- Subtext: "Patient consent required for every data transfer"

**Section 2: The Solution (Middle)**
- Icon: üõ°Ô∏è Shield
- Text: "No PHI = Network Benchmarking"
- Subtext: "Aggregate de-identified data freely"

**Section 3: 5 Use Cases (Bottom)**
- 5 cards in grid layout
- Each card:
  - Icon (scales, shield, dollar, chart, clipboard)
  - Use case name
  - ROI number ($50K, $120K, 15 hrs/mo, etc.)
  - One-sentence benefit

**Color Palette:**
- Background: Dark navy (#0f172a)
- Primary: Indigo (#6366f1)
- Accent: Cyan (#06b6d4) for financial data
- Warning: Yellow (#f59e0b) for alerts
- Success: Green (#10b981) for compliance

---

**Status:** ‚úÖ Visual specs complete  
**Next:** Create mockups or infographic  
**Priority:** üé® HIGH - Visual communication
